Related Experiment Video
Updated: May 4, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
[Protective effect of baicalin against LPS-induced intestinal injury]
Qiong Wu1, Hua Ye2, Yu-Zhen Zhu2
1Teaching and Research Room of Pharmacology, Guangdong Medical College, Zhanjiang 524023, China. wqzs2006@163.com
Objective:
To investigate the protective effect of baicalin on the intestinal mucosal injury caused by endotoxin-lipopolysaccharide (LPS) and the anti-oxidative injury in colonic and ileal mucosa of rats with septicopyemia.
Method:
Fifty healthy male BALB/c mice were randomly divided into 5 groups: the normal control group, the model group, and baicalin high-dose, medium-dose and low-dose groups. They were orally administered with double distilled water, 100 mg x kg(-1) of baicalin, 50 mg x kg(-1) of baicalin, and 25 mg x kg(-1) of baicalin respectively for three days, once a day. 1 h after the oral administration on 3 d, they were intraperitoneally injected with normal saline or LPS (17 mg x kg(-1)). At 20 h after the injection of LPS, all of the mice were sacrificed, and their colonic and ileal tissues were collected. The mental status, life state and death rate of mice in each group were observed, and the lengths of colonic were measured. Chiu's scoring method was used to assess the intestinal mucosal injury. Histopathological changes of intestinal tissues were tested by HE staining. The ultraviolet spectrophotometry was used to detect total antioxidant capacity (T-AOC), superoxide dismutase (T-SOD), and glutathione peroxidase (GSH-PX) of intestinal homogenate. The immunohistochemical method was used to analyze the expression of PCNA in intestinal tissues of each group.
Result:
The death of mice was observed after the intraperitoneal injection of LPS. The death rates of baicalin groups were remarkably lower than the death rate of the model group. The colons in the medium-dose baicalin group were much longer than that in the model group (P < 0.05), with a much lower intestinal mucosa injury degree than the model group. Colonic and ileal injuries in the high-dose baicalin group significantly (P < 0.05). Colonic and ileal injuries in the medium-dose baicalin group and the low-dose baicalin group significantly reduced compare with the model group (P < 0.000 1). The medium-dose baicalin group showed no significant increase in homogenate's T-AOC, T-SOD and GSH-PX compare with the model group (P < 0.05). There was no significant difference between baicalin groups and the model group in PCNA.
Conclusion:
Baicalin can protect intestinal epithelial cells suffering from injury from oxygen radicals, and relieve the intestinal injury caused by LPS by improving the intestinal mucosa structure and functions.
Insights
Baicalin significantly reduces intestinal injury and mortality in septicopyemia models. This natural compound protects against endotoxin-lipopolysaccharide (LPS) induced damage by improving gut mucosal integrity.
Area of Science:
- Pharmacology
- Toxicology
- Gastroenterology
Context:
- Sepsis-induced gut injury is a critical complication.
- Endotoxin-lipopolysaccharide (LPS) is a key mediator of septic shock.
- Intestinal mucosal barrier dysfunction contributes to sepsis progression.
Purpose:
- To evaluate the protective effects of baicalin against LPS-induced intestinal injury.
- To investigate the anti-oxidative properties of baicalin in the context of septicopyemia.
- To assess baicalin's impact on colonic and ileal mucosa in a rat model.
Summary:
- Baicalin administration reduced mortality rates in LPS-treated mice.
- Significant protection against colonic and ileal mucosal injury was observed with baicalin treatment.
- Histopathological analysis revealed improved intestinal structure in baicalin-treated groups.
- While antioxidant markers (T-AOC, T-SOD, GSH-PX) did not significantly increase, baicalin improved mucosal integrity.
Impact:
- Baicalin demonstrates therapeutic potential for managing sepsis-related gastrointestinal complications.
- Findings suggest baicalin's protective mechanism involves preserving intestinal mucosal structure and function.
- Further research into baicalin's specific anti-inflammatory and cytoprotective pathways is warranted.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018